T&L Co. Ltd Total Assets
T&L Co. Ltd total assets. Based on the latest financial reports, T&L Co. Ltd (340570) holds total assets worth ₩253.22 Billion KRW (≈ $171.60 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see T&L Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of T&L Co. Ltd (2017–2025)
Total assets of T&L Co. Ltd from 2017 to 2025. This chart illustrates how T&L Co. Ltd's total assets have evolved over time, based on quarterly financial data. See T&L Co. Ltd stock price for real-time trading data and today's change.
T&L Co. Ltd - Asset Composition Analysis
T&L Co. Ltd Total Assets Breakdown (December 2025)
T&L Co. Ltd total assets breakdown as of December 2025. T&L Co. Ltd's total assets of ₩253.22 Billion consist of 58.1% current assets and 41.9% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 34.0% |
| Accounts Receivable | ₩16.71 Billion | 7.7% |
| Inventory | ₩16.26 Billion | 7.5% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩3.74 Billion | 1.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how T&L Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is T&L Co. Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: T&L Co. Ltd's current assets represent 58.1% of total assets in 2025, an increase from 30.6% in 2017.
- Cash Position: Cash and equivalents constituted 34.0% of total assets in 2025, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 7.7% of total assets.
T&L Co. Ltd Competitors by Total Assets
Key competitors of T&L Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
T&L Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.69 | 6.99 | 5.00 |
| Quick Ratio | 4.88 | 5.96 | 4.05 |
| Cash Ratio | 0.00 | 0.00 | 1.34 |
| Working Capital | ₩132.46 Billion | ₩104.35 Billion | ₩41.31 Billion |
T&L Co. Ltd - Advanced Valuation Insights
This section examines the relationship between T&L Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.03 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 10.1% |
| Total Assets | ₩217.08 Billion |
| Market Capitalization | $255.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values T&L Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: T&L Co. Ltd's assets grew by 10.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for T&L Co. Ltd (2017–2025)
The table below shows the annual total assets of T&L Co. Ltd from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩217.08 Billion ≈ $147.11 Million |
+10.15% |
| 2024-12-31 | ₩197.08 Billion ≈ $133.56 Million |
+38.68% |
| 2023-12-31 | ₩142.11 Billion ≈ $96.30 Million |
+21.46% |
| 2022-12-31 | ₩117.00 Billion ≈ $79.29 Million |
+19.01% |
| 2021-12-31 | ₩98.31 Billion ≈ $66.62 Million |
+23.73% |
| 2020-12-31 | ₩79.45 Billion ≈ $53.84 Million |
+83.42% |
| 2019-12-31 | ₩43.32 Billion ≈ $29.36 Million |
+18.58% |
| 2018-12-31 | ₩36.53 Billion ≈ $24.76 Million |
+8.82% |
| 2017-12-31 | ₩33.57 Billion ≈ $22.75 Million |
-- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more